Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PAVmed (PAVM) Revenue (2021 - 2025)

PAVmed has reported Revenue over the past 5 years, most recently at $81000.0 for Q4 2025.

  • Quarterly results put Revenue at $81000.0 for Q4 2025, up 710.0% from a year ago — trailing twelve months through Dec 2025 was $100000.0 (down 95.0% YoY), and the annual figure for FY2025 was $100000.0, down 96.66%.
  • Revenue for Q4 2025 was $81000.0 at PAVmed, up from $5000.0 in the prior quarter.
  • Over the last five years, Revenue for PAVM hit a ceiling of $1.0 million in Q4 2023 and a floor of -$4000.0 in Q1 2021.
  • Median Revenue over the past 5 years was $166000.0 (2023), compared with a mean of $319058.8.
  • Biggest five-year swings in Revenue: soared 4825.0% in 2022 and later plummeted 99.39% in 2025.
  • PAVmed's Revenue stood at $300000.0 in 2021, then tumbled by 62.67% to $112000.0 in 2022, then soared by 836.61% to $1.0 million in 2023, then crashed by 99.05% to $10000.0 in 2024, then skyrocketed by 710.0% to $81000.0 in 2025.
  • The last three reported values for Revenue were $81000.0 (Q4 2025), $5000.0 (Q3 2025), and $6000.0 (Q2 2025) per Business Quant data.